Cohort Studyhigh evidence
Steatotic Liver Disease Risk Scores to Predict Cirrhosis and Hepatocellular Carcinoma.
JAMA internal medicine·September 21, 2026·PMID 42766290
Why it mattersSelecting which patients with steatotic liver disease warrant surveillance for advanced liver disease is a common clinical challenge. This large VA cohort provides comparative performance data for readily available risk scores, helping clinicians choose tools that balance detection of cirrhosis with avoiding unnecessary testing.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled